Eli Lilly Files Trademarks for COV-BEAT, COV-BLOCK & COV-BARRIER

Eli Lilly and Company filed three new trademark applications on April 13 for “COV-BEAT,” “COV-BLOCK,” and “COV-BARRIER.”

The applications were all filed on a 1(b) basis, meaning that Eli Lilly was required to sign a declaration stating that it has a bona fide intent to use the trademarks in association with the goods and services listed.

The three filings included “medical and scientific research in the field of coronavirus and infectious diseases” as the services that Eli Lilly intends to use the trademarks in connection with.

While a phrase like “COV-BARRIER” may sound like a treatment for the coronavirus, the company states that the name will only reference research into viruses.

In order to achieve registration, Eli Lilly and Company will need to prove that they have started using the marks in commerce, so we can assume the company has something in the pipeline.

• SHARE THIS ARTICLE ON:

Josh Gerben, Esq.

Josh Gerben, Esq. is the founder and principal of Gerben IP. In 2008, Mr. Gerben started the firm to provide high-quality trademark services at reasonable prices. Today, he is recognized by the World Trademark Review as a top trademark filer, having registered over 7,500 trademarks. The contents of this blog are for informational purposes only and may not be relied on as legal advice.